No Matches Found
No Matches Found
No Matches Found
Raaj Medisafe India Ltd
Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO
Raaj Medisafe India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO
Raaj Medisafe India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 February 2026, providing investors with the most recent insights into the stock’s performance and fundamentals.
Are Raaj Medisafe India Ltd latest results good or bad?
Raaj Medisafe India Ltd's latest results are positive, showing a 44.2% revenue growth to ₹62.00 crores and a net profit that doubled to ₹6.00 crores, despite concerns over high leverage and rising interest costs. Overall, the company demonstrates strong operational performance and growth potential.
Raaj Medisafe India Q3 FY26: Strong Growth Momentum Continues Despite Margin Pressures
Raaj Medisafe India Limited, a micro-cap medical disposables manufacturer, continues its impressive growth trajectory with annual revenue reaching ₹62.00 crores in FY25, marking a robust 44.2% year-on-year expansion. The Madhya Pradesh-based company, with a market capitalisation of ₹119.00 crores, has demonstrated remarkable resilience in the packaging sector, delivering net profit of ₹6.00 crores despite operating in a capital-intensive business environment. The stock, currently trading at ₹90.00, has delivered exceptional long-term returns with a 5-year gain of 831.68%, significantly outperforming the Sensex's 62.54% return over the same period.
Are Raaj Medisafe India Ltd latest results good or bad?
Raaj Medisafe India Ltd's latest results are strong, showing a net profit of ₹6.00 crores and a 44.2% revenue growth in FY25, despite facing challenges with elevated leverage and slight operating margin compression. Overall, the company demonstrates robust operational performance but must manage its debt and market conditions.
Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO
Raaj Medisafe India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with the latest insights into its performance and outlook.
When is the next results date for Raaj Medisafe India Ltd?
The next results date for Raaj Medisafe India Ltd is 11 February 2026.
Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO
Raaj Medisafe India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 2 January 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into its performance and outlook.
Raaj Medisafe India Ltd Upgraded to Hold on Improving Technicals and Strong Financials
Raaj Medisafe India Ltd has seen its investment rating upgraded from Sell to Hold as of 2 January 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This shift comes amid a backdrop of strong quarterly financial performance and a more constructive technical outlook, signalling cautious optimism for investors in the packaging sector.
Raaj Medisafe India Ltd is Rated Sell
Raaj Medisafe India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with the latest insights into its performance and outlook.
Raaj Medisafe Sees Revision in Market Evaluation Amid Mixed Financial Signals
Raaj Medisafe, a microcap player in the packaging sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a comprehensive view of its current standing.
Raaj Medisafe India: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals
Raaj Medisafe India, a key player in the packaging sector, has experienced a revision in market assessment driven by a combination of technical indicators and fundamental financial data. Despite demonstrating robust long-term growth and positive quarterly results, the stock’s recent performance and technical trends have influenced a nuanced shift in its evaluation metrics.
How has been the historical performance of Raaj Medisafe?
Raaj Medisafe has shown significant growth from March 2019 to March 2025, with net sales increasing from 4.80 Cr to 62.42 Cr and a turnaround from losses to profits in operating profit, profit before tax, and profit after tax. Total assets rose from 13.59 Cr to 68.06 Cr, indicating strong financial recovery and growth.
Raaj Medisafe India Faces Intense Selling Pressure Amid Consecutive Losses
Raaj Medisafe India has encountered significant selling pressure today, with the stock registering a sharp decline of 5.00% and exhibiting a complete absence of buyers. This distress selling signals a challenging phase for the packaging company as it continues to underperform against key market benchmarks over multiple time frames.
Raaj Medisafe India Faces Intense Selling Pressure Amid Consecutive Losses
Raaj Medisafe India has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. The packaging sector company’s shares opened sharply lower and remained at intraday lows, signalling distress selling and a lack of demand from investors.
Raaj Medisafe India Faces Intense Selling Pressure Amid Lower Circuit Lockdown
Raaj Medisafe India Ltd has encountered severe selling pressure today, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme market behaviour signals distress selling and a lack of buyer interest, marking a challenging phase for the packaging sector company.
Raaj Medisafe India Faces Intense Selling Pressure Amid Lower Circuit Status
Raaj Medisafe India Ltd has entered a phase of extreme selling pressure, registering a lower circuit with only sell orders in the queue. The stock’s trading activity today signals distress selling, with no buyers present to absorb the supply, marking a significant moment for investors in the packaging sector.
Raaj Medisafe India Ltd Gains 1.44% Over Week, Trading Above 5-Day and 20-Day Averages
Raaj Medisafe India Ltd, a microcap in the packaging sector, is experiencing notable buying activity despite a recent decline. While it has underperformed the Sensex over shorter periods, it has shown significant long-term growth. The stock is currently trading above some moving averages, indicating mixed momentum.
Raaj Medisafe Reports Strong Sales Growth Amidst Liquidity Concerns and Performance Fluctuations
Raaj Medisafe India, a microcap in the packaging sector, reported strong financial results for the quarter ending September 2025, with significant growth in profit after tax and net sales. However, challenges include negative operating cash flow and a need for improved capital efficiency, alongside fluctuating stock performance compared to the Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
